Whereas the lack of anti-leukemic effect of IFNα in the mouse model used in our study could also be due to the absence of important immune cells needed for an effective DC effect against AML cells (Ito et al. 2002), the BNML rat model has an intact immune system. Here, IFNA2 is linked to acute myeloid leukemia.